The Effect of Cigarette Smoke Exposure on Efferocytosis in Chronic Obstructive Pulmonary Disease; Molecular Mechanisms and Treatment Opportunities. (2nd November 2021)

• Record Type: Journal Article
• Authors: Tajbakhsh, Amir; Gheibihayat, Seyed Mohammad; Mortazavi, Deniz; Medhati, Pourya; Rostami, Behrouz; Savardashtaki, Amir; Momtazi-Borojeni, Amir Abbas
• Is Part Of: COPD. Volume 18:Number 6(2021)
• Page Start: 723
• Page End: 736
• Publication Date: 2021-11-02
• Subjects: Apoptosis -- cigarette smoke -- COPD -- efferocytosis -- inflammation -- necrosis -- neutrophil; Lungs -- Diseases, Obstructive -- Periodicals; 616.24
• DOI: 10.1080/15412555.2021.1978419
• Languages: English
• ISSNs: 1541-2555

Abstract

Abstract: Cigarette smoking-related inflammation, cellular stresses, and tissue destruction play a key role in lung disease, such as chronic obstructive pulmonary disease (COPD). Notably, augmented apoptosis and impaired clearance of apoptotic cells, efferocytosis, contribute to the chronic inflammatory response and tissue destruction in patients with COPD. Of note, exposure to cigarette smoke can impair alveolar macrophages efferocytosis activity, which leads to secondary necrosis formation and tissue inflammation. A better understanding of the processes behind the effect of cigarette smoke on efferocytosis concerning lung disorders can help to design more efficient treatment approaches and also delay the development of lung disease, such as COPD. To this end, we aimed to seek mechanisms underlying the impairing effect of cigarette smoke on macrophages-mediated efferocytosis in COPD. Further, available therapeutic opportunities for restoring efferocytosis activity and ameliorating respiratory tract inflammation in smokers with COPD were also discussed.